CHINA REPORT INTELLECTUAL PROPERTY
 
|
HOT POINT
|
|
|
|
 
20160217China's IP in foreign eyes
Author:CopyFrom:hits:1678UpdateTime:2016/2/19 13:45:04Editor:

China plans to launch some 40 Beidou navigation satellites by 2020 to support its global navigation and positioning network, which will provide global coverage with positioning accuracy of less than 10 metres and timing accuracy of 20 nanoseconds.  Major navigation systems, such as the US-based GPS and Russia's GLONASS, use about 24 satellites, but Beidou, with 35 satellites, will be more accurate after it achieves global coverage. (China to launch about 40 Beidou satellites by 2020, by the Times of India)
  到2020年,中国计划发射近40颗具有全球导航和定位功能的北斗导航卫星。未来这一导航系统将覆盖全球,达到10米的定位精度和20纳秒的授时精度。包括美国全球定位系统和俄罗斯格洛纳斯卫星导航系统在内的现有主要导航系统使用约24颗卫星,而北斗系统将使用约35颗。(到2020年中国将发射近40颗北斗卫星,印度时报)
Comment:
    With more and more satellites launched, the independent research and development positioning system, Beidou Navigation System has shown a promising application prospect, which may play an important role in areas like national security, maritime transport and scientific research in China .
点评:
  随着越来越多的卫星发射上天,中国自行研制的北斗卫星导航系统显示出的良好的应用前景,这将为中国在国家安全、海洋运输和科学研究等领域的发展发挥重要作用。
Many industry experts believe that a new era of Chinese innovation in bio-pharma may be soon upon us. The excitement of pharmaceutical executives and investors at the recent BioCentury China healthcare conference was palpable, fueled by a flurry of new measures announced by the China Food and Drug Administration (CFDA), following guidance by the State Council. (This is What Industry Experts Told us About Pharma Innovation in China, by McKinsey)
  不少制药从业者对中国生物制药行业的未来持乐观态度,这源于在国务院的指导下,国家食品药品监督管理总局推行的一系列新政。有专家认为,中国生物制药领域即将迎来新的创新时代。(行业专家如何看待中国的医药创新,麦肯锡)
Comment:
    CFDA have taken a series of measures to promote bio-medical as a strategic industry. Changes at the top of the CFDA, real efforts to clear the backlog of new drug applications, the continuous wave of returning talent, and improving funding conditions are indicators that China is well on its way to becoming a biopharma innovation powerhouse.
点评:
  中国政府已经采取了一系列措施促进生物制药行业的发展,包括管理体制改革,处理积压的新药审批案件,鼓励优秀人才归国,提升资金状况等。这些措施为中国未来生物医药行业的持续创新提供了源源不断的动力。
 (孙易恒)

 
京ICP备06005384

中国知识产权报版权所有 未经允许不得以任何形式复制转载